Human MDR1 and MRP1 recognize berberine as their transport substrate

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 1, 2007, Pages 242-245

  Shitan, Nobukazu ^a   Tanaka, Miyako ^b   Terai, Koichiro ^b   Ueda, Kazumitsu ^b   Yazaki, Kazufumi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

ATP binding cassette (ABC) transporter; Berberine; Multidrug resistance protein (MDR); Multidrug resistance associated protein (MRP); Transport

Indexed keywords

ATP-BINDING CASSETTE (ABC) TRANSPORTER; BERBERINE; MULTIDRUG RESISTANCE PROTEIN (MDR); MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP);

ADENOSINETRIPHOSPHATE; CELLS; GROWTH KINETICS; METABOLISM; SUBSTRATES;

PROTEINS;

ADENOSINE TRIPHOSPHATE; BERBERINE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; DRUG EFFECT; ENZYME SPECIFICITY; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ADENOSINE TRIPHOSPHATE; BERBERINE; BIOLOGICAL TRANSPORT; CELL LINE; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; SUBSTRATE SPECIFICITY;

EID: 33846547591     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60441     Document Type: Article

References (23)

1. Iwasa, K., Nanba, H., Lee, D. U., and Kang, S. I., Structure-activity relationships of protoberberines having antimicrobial activity. Planta Med., 64, 748-751 (1998).
2. Yamamoto, K., Takase, H., Abe, K., Saito, Y., and Suzuki, A., Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba. Nippon Yakurigaku Zasshi, 101, 169-175 (1993).
3. Misik, V., Bezakova, L., Malekova, L., and Kostalova, D., Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. Planta Med., 61, 372-373 (1995).
4. Sethi, M. L., Enzyme inhibition. VI: Inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships. J. Pharm. Sci., 72, 538-541 (1983).
5. Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., and Fujiwara, H., Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol., 66, 227-233 (1999).
6. Taylor, C. T., and Baird, A. W., Berberine inhibition of electrogenic ion transport in rat colon. Br. J. Pharmacol., 116, 2667-2672 (1995).
7. Taylor, C. T., Winter, D. C., Skelly, M. M., O'Donoghue, D. P., O'Sullivan, G. C., Harvey, B. J., and Baird, A. W., Berberine inhibits ion transport in human colonic epithelia. Eur. J. Pharmacol., 368, 111-118 (1999).
8. Chang, K. S., Gao, C., and Wang, L. C., Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells. Cancer Lett., 55, 103-108 (1990).
9. Lee, M. K., and Kim, H. S., Inhibitory effects of protoberberine alkaloids from the roots of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med., 62, 31-34 (1996).
10. Ghosh, A. K., Bhattacharyya, F. K., and Ghosh, D. K., Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp. Parasitol., 60, 404-413 (1985).
11. Liu, J. C., Chan, P., Chen, Y. J., Tomlinson, B., Hong, S. H., and Cheng, J. T., The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology, 59, 283-289 (1999).
12. Wang, Y. X., and Zheng, Y. M., Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. J. Cardiovasc. Pharmacol., 30, 214-222 (1997).
13. Chiou, W. F., Yen, M. H., and Chen, C. F., Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur. J. Pharmacol., 204, 35-40 (1991).
14. Wong, K. K., Mechanism of the aortic relaxation induced by low concentrations of berberine. Planta Med., 64, 756-757 (1998).
15. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I., Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84, 3004-3008 (1987).
16. Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., and Lewis, K., Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 50-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA, 97, 1433-1437 (2000).
17. Lin, H. L., Liu, T. Y., Wu, C. W., and Chi, C. W., Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel. Br. J. Cancer, 81, 416-422 (1999).
18. He, L., and Liu, G. Q., Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacol. Sinica, 23, 591-596 (2002).
19. He, L., and Liu, G. Q., Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol. Sinica, 23, 423-429 (2002).
20. Efferth, T., Davey, M., Olbrich, A., Rucker, G., Gebhart, E., and Davey, R., Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis., 28, 160-168 (2002).
21. Taguchi, Y., Kino, K., Morishima, M., Komano, T., Kane, S. E., and Ueda, K., Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Biochemistry, 36, 8883-8889 (1997).
22. Taguchi, Y., Yoshida, A., Takada, Y., Komano, T., and Ueda, K., Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett., 401, 11-14 (1997).
23. Borst, P., Evers, R., Kool, M., and Wijnholds, J., A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst., 92, 1295-1302 (2000).